176 related articles for article (PubMed ID: 38035072)
21. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report.
Iesaka H; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Abe T; Shinohara N; Atsumi T
Medicine (Baltimore); 2023 Dec; 102(51):e36664. PubMed ID: 38134115
[TBL] [Abstract][Full Text] [Related]
22. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Gu YC; Liu Y; Xie C; Cao BS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
[TBL] [Abstract][Full Text] [Related]
23. Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
Asari Y; Kageyama K; Sugiyama A; Kogawa H; Niioka K; Daimon M
Endocr J; 2019 Jun; 66(6):515-522. PubMed ID: 30880293
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
[TBL] [Abstract][Full Text] [Related]
25. Ontogenic development of corticotrophs in fetal buffalo (Bubalus bubalis) pituitary gland.
Sandhu MA; Saeed AA; Khilji MS; Pasha RH; Mukhtar N; Anjum MS
Eur J Histochem; 2014 Jan; 58(1):2292. PubMed ID: 24704996
[TBL] [Abstract][Full Text] [Related]
26. Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease.
Zhang D; Damoiseaux R; Babayan L; Rivera-Meza EK; Yang Y; Bergsneider M; Wang MB; Yong WH; Kelly K; Heaney AP
J Clin Endocrinol Metab; 2021 Jan; 106(1):e232-e246. PubMed ID: 33000123
[TBL] [Abstract][Full Text] [Related]
27. Pro-opiomelanocortin expression in a metastatic breast carcinoma with ectopic ACTH secretion.
Pelte MF; Schwaller J; Cerrato C; Meier CA
Breast J; 2004; 10(4):350-4. PubMed ID: 15239795
[TBL] [Abstract][Full Text] [Related]
28. HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency.
Ono M; Fukuda I; Nagao M; Tomiyama K; Okazaki-Hada M; Shuto Y; Kobayashi S; Yamaguchi Y; Nagamine T; Nakajima Y; Inagaki-Tanimura K; Sugihara H
Pituitary; 2022 Aug; 25(4):615-621. PubMed ID: 35653047
[TBL] [Abstract][Full Text] [Related]
29. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
30. Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
Müller-Jensen L; Knauss S; Ginesta Roque L; Schinke C; Maierhof SK; Bartels F; Finke C; Rentzsch K; Ulrich C; Mohr R; Stenzel W; Endres M; Boehmerle W; Huehnchen P
Front Immunol; 2023; 14():1108116. PubMed ID: 36845122
[TBL] [Abstract][Full Text] [Related]
31. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition.
Urai S; Iguchi G; Kanie K; Bando H; Yamamoto M; Oi Y; Kashitani Y; Iida K; Kanzawa M; Fukuoka H; Takahashi M; Shintani Y; Ogawa W; Takahashi Y
Eur J Endocrinol; 2024 Jan; 190(1):K1-K7. PubMed ID: 38146732
[TBL] [Abstract][Full Text] [Related]
32. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature.
Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A
BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911
[TBL] [Abstract][Full Text] [Related]
33. Hypophysitis Induced by Sintilimab in the Treatment of Bladder Cancer: A Case Report.
Li R; Jiang B; Zhu Y; Gao L; Zhou Y; Yang S
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):606-610. PubMed ID: 37818555
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line.
Gentilin E; Borges De Souza P; Ambrosio MR; Bondanelli M; Gagliardi I; Zatelli MC
J Endocrinol Invest; 2023 Dec; 46(12):2609-2616. PubMed ID: 37233978
[TBL] [Abstract][Full Text] [Related]
35. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
36. Reversible impairment of the processing of proopiomelanocortin into ACTH in pituitary enlargement suspected of lymphocytic hypophysitis.
Akahori H
Endocr J; 2012; 59(12):1121-9. PubMed ID: 23064477
[TBL] [Abstract][Full Text] [Related]
37. Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.
Nguyen H; Shah K; Waguespack SG; Hu MI; Habra MA; Cabanillas ME; Busaidy NL; Bassett R; Zhou S; Iyer PC; Simmons G; Kaya D; Pitteloud M; Subudhi SK; Diab A; Dadu R
Endocr Relat Cancer; 2021 Jun; 28(7):419-431. PubMed ID: 33890870
[TBL] [Abstract][Full Text] [Related]
38. Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence.
Rees DA; Hepburn PJ; McNicol AM; Francis K; Jasani B; Lewis MD; Farrell WE; Lewis BM; Scanlon MF; Ham J
Mol Cell Endocrinol; 2002 Mar; 189(1-2):51-7. PubMed ID: 12039064
[TBL] [Abstract][Full Text] [Related]
39. Effects of tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells.
Hagiwara R; Kageyama K; Iwasaki Y; Niioka K; Daimon M
Endocr J; 2022 Sep; 69(9):1053-1060. PubMed ID: 35296577
[TBL] [Abstract][Full Text] [Related]
40. Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists.
Druce I; Tawagi K; Shaw JLV; Ibrahim A; Lochnan H; Ong M
Curr Oncol; 2022 Jul; 29(7):4665-4677. PubMed ID: 35877230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
